Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 27.e1-27.e6

  Yafi, Faysal A ^a   Brimo, Fadi ^a   Auger, Manon ^a   Aprikian, Armen ^a   Tanguay, Simon ^a   Kassouf, Wassim ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Bladder cancer; Cancer detection; Cancer surveillance; Sensitivity; Specificity; Urinary biomarkers; Urine cytology

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINALYSIS; URINE CYTOLOGY; VERY ELDERLY; CYTOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS; URINE;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; URINE;

EID: 84890788198     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.09.011     Document Type: Article

References (19)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
2. Babjuk M., Oosterlinck W., Sylvester R., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008, 54:303-314.
3. Rubben H., Lutzeyer W., Fischer N., et al. Natural history and treatment of low and high risk superficial bladder tumors. J Urol 1988, 139:283-285.
4. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: progression and recurrence. J Urol 1983, 130:1083-1086.
5. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., et al. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 2000, 164:680-684.
6. Wright M.P., Jones D.J. Surveillance for bladder cancer: the management of 4.8 million people. South-west urologists. Br J Urol Int 2000, 85:431-433.
7. Mariappan P., Smith G. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J. Urol 2005, 173:1108-1111.
8. Papanicolaou G.N., Marshall V.F. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 1945, 18:519-520.
9. Raitanen M.-P., Aine R., Rintala E., et al. Differences between local and review urinary cytology and diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 2002, 41:284-289.
10. Paez A., Coba J.M., Murillo N., et al. Reliability of the routine cytological diagnosis in bladder cancer. Eur Urol 1999, 35:228-232.
11. Budman L.I., Kassouf W., Steinberg J.R. Biomarkers for detection and surveillance of bladder cancer. Can Urol Assoc J 2008, 2:212-221.
12. Lopez-Beltran A., Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 2004, 46:170-176.
13. Brimo F., Vollmer R.T., Case B., Aprikian A.G., Kassouf W., Auger M. Accuracy of urine cytology and the significance of an atypical category. Am J Clin Pathol 2009, 132:785-793.
14. Bastacky S., Ibrahim S., Wilczynski S.P., et al. The accuracy of urinary cytology in daily practice. Cancer 1999, 87:118-128.
15. Karakiewicz P.I., Benayoun S., Zippe C., et al. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. Br J Urol Int 2006, 97:997-1001.
16. Raab S.S., Grzybicki D.M., Vrbin C.M., et al. Urine cytology discrepancies: frequency, causes and outcomes. Am J Clin Pathol 2007, 127:946-953.
17. Halling K.C., King W., Sokolva I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000, 164:1768-1775.
18. Vrooman O.P., Witjes J.A. Urinary markers in bladder cancer. Eur Urol 2008, 53:909-916.
19. Yoder B.J., Skacel M., Hedgepeth R., et al. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings. Am J Clin Pathol 2007, 127:295-301.